Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety Evaluation of 10 or 13-valent Pneumococcal Conjugate Vaccine in Children and 23-valent Pneumococcal Polysaccharide Vaccine in Elderly Adults.

NCT04551248 is registered in ClinicalTrials.gov with Sungkyunkwan University as lead sponsor.

NCT NCT04551248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety Evaluation of 10 or 13-valent Pneumococcal Conjugate Vaccine in Children and 23-valent Pneumococcal Polysaccharide Vaccine in Elderly Adults.
Lead sponsor
Sungkyunkwan University
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2021
Completion date
March 31, 2022
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal vaccine adverse reaction